Evaluation of the Effect of an Emergency Department Information Video on the Risk of Post-Traumatic Stress Disorder 30 Days After an Emergency Visit.
VISU
2 other identifiers
observational
750
0 countries
N/A
Brief Summary
Post-traumatic stress disorder (PTSD) is a psychological disorder characterized by the re-experiencing of distressing symptoms, avoidance of traumatic memories and physiological hyperarousal in people who have been exposed to a traumatic event. The consequences of PTSD are manifold: financial, quality of life, absenteeism, morbidity, and mortality. An emergency department visit can be a traumatic event and associated with anxiety. Studies have explored the prevalence and factors associated with the occurrence of PTSD among a selected population of patients admitted to the emergency department for either cardiological or traumatological reasons. The prevalence of PTSD at 1 month varied among these populations, from 12% to 25%. Several factors have been described that could be independently associated with an increased risk of developing PTSD: factors linked to the patient himself (basal state and severity of acute pathology) or to the patient pathway (care structure, care modalities, waiting time). Given the serious medical, psycho-social and economic consequences of PTSD, it is important to identify the risk factors that can be controlled during a patient's stay in the emergency department. In 2025, a general information procedure for patients and next of kin will be deployed in three emergency departments. The aim of this procedure is to improve the quality of the information provided to emergency patients, thereby enhancing the experience of patients and those accompanying them. It will consist of video support delivering standardized information to patients from the moment they arrive in the emergency department until they are discharged. These videos will describe the patient's journey through the emergency department. The aim of this study is to evaluate the effect of this information procedure on the risk of developing PTSD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2025
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 24, 2024
CompletedFirst Posted
Study publicly available on registry
January 1, 2025
CompletedStudy Start
First participant enrolled
February 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2026
CompletedJanuary 1, 2025
December 1, 2024
11 months
December 24, 2024
December 24, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Occurence PTSD
assessed by calculation of PCL-5 score
DaAy 30
Secondary Outcomes (2)
Identify factors associated with the occurrence of PTSD
Day 30
HAD score at D30
Day 30
Study Arms (2)
BEFORE
Group pf patients enrolled Before the information procedure was set up
AFTER
Group pf patients enrolled After the information procedure was set up
Eligibility Criteria
Any adult patient coming for an unscheduled emergency consultation
You may qualify if:
- Age ≥ 18 years
- Triage level 1, 2, 3 by the triage nurse (according to CIMU, FRENCH or other scale used locally)
- Non-opposition to participation in the study after information and delivery of the information note
- Possibility of 30-day follow-up (self-questionnaire to be completed by e-mail)
- Patient with cognitive or sensory capacity to view and understand information videos
You may not qualify if:
- Inability to consent (neurological disorder, coma, acute intoxication, cognitive impairment)
- Patient does not have a good understanding of the French language.
- Estimated life expectancy less than 6 months
- Participation in other clinical intervention research
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jennifer TRUCHOT, MD, PhD
Assistance Publique - Hôpitaux de Paris
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 24, 2024
First Posted
January 1, 2025
Study Start
February 1, 2025
Primary Completion
January 1, 2026
Study Completion
January 1, 2026
Last Updated
January 1, 2025
Record last verified: 2024-12